Mike Pancione
About Mike Pancione
Mike Pancione serves as the Director of National Accounts at Nevro, having previously held various roles at Stryker and Nevro over a span of nearly two decades. He holds a B.A. in Economics and English from Lafayette College and has a strong interest in leadership positions within startups focused on disruptive technologies.
Current Role at Nevro
Mike Pancione serves as the Director of National Accounts at Nevro, a position he has held since 2023. In this role, he is responsible for managing key accounts and developing strategic relationships to enhance the company's market presence. His experience in sales and account management contributes to Nevro's objectives in the medical technology sector.
Previous Experience at Nevro
Prior to his current role, Mike Pancione worked at Nevro in various capacities. He served as District Sales Manager from 2015 to 2018, followed by a position as Regional Sales Director from 2018 to 2022. His tenure at Nevro involved overseeing sales operations and driving growth in the Atlanta, Georgia area.
Experience at Stryker
Mike Pancione has extensive experience at Stryker, where he held multiple roles. He began as a Marketing Associate in Clinical Education from 2005 to 2006, followed by a position as Associate Product Manager for Vertebral Compression Fracture from 2006 to 2007. He then transitioned to a Sales Representative role from 2007 to 2015, where he focused on sales strategies and customer engagement in Atlanta, Georgia.
Education and Academic Background
Mike Pancione studied at Lafayette College from 2001 to 2005, where he earned a Bachelor of Arts degree. His academic focus included Economics and English, providing him with a strong foundation for his career in business and sales.
Interests in Technology and Leadership
Mike Pancione has a keen interest in leadership roles within venture capital-funded startups that focus on disruptive technology. He is particularly interested in fields such as nanomedicine, CRISPR, regenerative therapies, and neuromodulation, reflecting his commitment to advancing innovative solutions in healthcare.